Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) in dogs

By Fekadu M.   Nesby S.L.   Shaddock J.H.   Schumachert C.L.   Linhart S.B.   Sanderlin D.W.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 465-468

Elsevier

Access to resources Recommend Favorite

Innocuity studies of SAG-2 oral rabies vaccine in various Zimbabwean wild non-target species

By Bingham J.   Schumacher C.L.   Aubert M.F.A.   Hill F.W.G.   Aubert A.  

Vaccine, Vol. 15, Iss. 9, 1997-06 ,pp. : 937-943

Elsevier

Access to resources Recommend Favorite

Evaluation of the safety of two attenuated oral rabies vaccines, SAG1 and SAG2, in six Arctic mammals

By Follmann E.H.   Ritter D.G.   Baer G.M.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 270-273

Elsevier

Access to resources Recommend Favorite

Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination

By Orciari L.A.   Niezgoda M.   Hanlon C.A.   Shaddock J.H.   Sanderlin D.W.   Yager P.A.   Rupprecht C.E.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4511-4518

Elsevier

Access to resources Recommend Favorite

Safety study of the SAG 2 rabies virus mutant in several non-target species with a view to its future use for the immunization of foxes in Europe

By Masson E.   Cliquet F.   Aubert M.   Barrat J.   Aubert A.   Artois M.   Schumacher C.L.  

Vaccine, Vol. 14, Iss. 16, 1996-11 ,pp. : 1506-1510

Elsevier

Access to resources Recommend Favorite